Passive

Invesco NASDAQ Future Gen 200 ETF

The Invesco NASDAQ Future Gen 200 ETF (the “Fund”) seeks to track the investment results (before fees and expenses) of the Nasdaq Innovators Completion Cap IndexTM (the “Underlying Index”).

$25.64

-16.4% last 12 months

Compare similar ETFs

Fund Size
Dividend
Fees
Current
NASDAQ Future Gen 200 ETF QQQS
Fund Size
$12.8 Million
Dividend
0.6%
Fees
-
Total Stock Market Index Fund VTI
Fund Size
$1.46 Trillion
Dividend
1.4%
Fees
0.03%
500 Index Fund VOO
Fund Size
$982 Billion
Dividend
1.4%
Fees
0.03%
Total International Stock Index Fund VXUS
Fund Size
$404 Billion
Dividend
3.2%
Fees
0.07%
Core S&P 500 ETF IVV
Fund Size
$402 Billion
Dividend
1.4%
Fees
0.03%
View 1291 similar ETFs →

Average metrics of all companies in portfolio

Compare to
Market
Market Cap The market value of the company. It's calculated by multiplying the share price by the number of outstanding shares. $1.5 Billion
Dividend Yield Yearly payout to shareholders per share. The percentage indicates the payout in relation to the share price. 0.25 %
Beta Indicates the relationship between the price performance of a share and the market. 0.0252
P/E Ratio Ratio between share price and earnings per share. A low ratio could indicate that the stock is undervalued or investors aren't expecting high growth. A high ratio could indicate that the stock is overvalued or investors are expecting high growth. 58.47
Negative P/E Ratio a negative P/E ratio shows that the company is not profitable, and it shows how many years it would take the company to lose its entire market capitalisation if it did not change anything -63.97
Profitable Companies 27
PEG The ratio between the P/E ratio and the growth rate of the company's earnings per share in the last twelve months. A lower PEG could mean that a stock is undervalued. 75.16
Price to Sales Ratio Market cap divided by the revenue in the most recent year. 4.33
Price to Book Ratio Price to Book Ratio is the Market cap divided by the Book value of the company 3.0
Compare to
Market
Enterprise Value to EBIT Enterprise Value divided by EBIT -2.85
Enterprise Value to Revenue Enterprise value divided by revenue 47.5
Total Debt to Enterprise Value Total debt divided by enterprise value 0.17
Debt to Equity A higher ratio indicates a higher risk. However, the ratio is difficult to compare between industries where common amounts of debt vary. 0.3444
Profit Margin Net income divided by revenue of the last 4 quarters. It indicates the company's profitability. -977.65%
Quarterly Earnings Growth (YoY) The rate at which the company's net income has increased to the same quarter one year ago. -
Return on Equity Equity divided by market cap. -25.27%
Return on Assets Indicates a company's profitability in relation to its total assets. -17.69%
Return on Invested Capital Return on invested capital (ROIC) is net income after dividends divided by the sum of debt and equity. It shows how effective a company is at turning capital invested by shareholders and other debtholders into profits. -19.95%

Industries

Healthcare 47.3%
Technology 30.4%
Industrials 8.2%
Consumer Discretionary 4.8%
Materials 1.9%
Other 1.0%
Energy 0.5%
Telecommunications 0.5%
N/A 5.3%

Market cap

Micro Cap 22%
Small Cap 52%
Mid Cap 26%
Large Cap 0%
Mega Cap 0%

207 Investments

P/E-Ratio
Total Investment
Weight
Invesco Private Prime Fund logo

Invesco Private Prime Fund

P/E-Ratio
n/a
Total Investment
$3.3 Million
Weight
40.0%
Invesco Private Government Fund logo

Invesco Private Government Fund

P/E-Ratio
n/a
Total Investment
$1.28 Million
Weight
15.5%
Ocular Therapeutix, Inc. logo

OCUL - Manufacturing

Ocular Therapeutix, Inc.

P/E-Ratio
-11.2
Total Investment
$133 Thousand
Weight
1.6%
Altimmune, Inc. logo

ALT - Manufacturing

Altimmune, Inc.

P/E-Ratio
0.0
Total Investment
$127 Thousand
Weight
1.5%
Mersana Therapeutics, Inc. logo

MRSN - Manufacturing

Mersana Therapeutics, Inc.

P/E-Ratio
-2.4
Total Investment
$109 Thousand
Weight
1.3%
Fate Therapeutics, Inc. logo

FATE - Manufacturing

Fate Therapeutics, Inc.

P/E-Ratio
-2.9
Total Investment
$94.3 Thousand
Weight
1.1%
Iovance Biotherapeutics, Inc. logo

IOVA - Manufacturing

Iovance Biotherapeutics, Inc.

P/E-Ratio
0.0
Total Investment
$86.8 Thousand
Weight
1.1%
Kodiak Sciences Inc. logo

KOD - Manufacturing

Kodiak Sciences Inc.

P/E-Ratio
0.0
Total Investment
$82.3 Thousand
Weight
1.0%
Lexicon Pharmaceuticals, Inc. logo

LXRX - Manufacturing

Lexicon Pharmaceuticals, Inc.

P/E-Ratio
-2.4
Total Investment
$77.8 Thousand
Weight
0.9%
Alpine Immune Sciences, Inc. logo

ALPN - Manufacturing

Alpine Immune Sciences, Inc.

P/E-Ratio
-131.6
Total Investment
$75.2 Thousand
Weight
0.9%
MacroGenics, Inc. logo

MGNX - Manufacturing

MacroGenics, Inc.

P/E-Ratio
-105.1
Total Investment
$72.4 Thousand
Weight
0.9%
Kura Oncology, Inc. logo

KURA - Manufacturing

Kura Oncology, Inc.

P/E-Ratio
0.0
Total Investment
$72.2 Thousand
Weight
0.9%
Heron Therapeutics, Inc. logo

HRTX - Manufacturing

Heron Therapeutics, Inc.

P/E-Ratio
0.0
Total Investment
$71.1 Thousand
Weight
0.9%
Gritstone bio, Inc. logo

GRTS - Manufacturing

Gritstone bio, Inc.

P/E-Ratio
-0.7
Total Investment
$70.8 Thousand
Weight
0.9%
Arvinas, Inc. logo

ARVN - Manufacturing

Arvinas, Inc.

P/E-Ratio
-6.0
Total Investment
$69.6 Thousand
Weight
0.8%
Ardelyx, Inc. logo

ARDX - Manufacturing

Ardelyx, Inc.

P/E-Ratio
0.0
Total Investment
$68.5 Thousand
Weight
0.8%
Omeros Corp. logo

OMER - Manufacturing

Omeros Corp.

P/E-Ratio
-1.7
Total Investment
$68.1 Thousand
Weight
0.8%
Codexis, Inc. logo

CDXS - Manufacturing

Codexis, Inc.

P/E-Ratio
0.0
Total Investment
$65.3 Thousand
Weight
0.8%
Merus N.V. logo

MRUS - Manufacturing

Merus N.V.

P/E-Ratio
0.0
Total Investment
$65 Thousand
Weight
0.8%
Silk Road Medical, Inc. logo

SILK - Manufacturing

Silk Road Medical, Inc.

P/E-Ratio
-13.4
Total Investment
$63.8 Thousand
Weight
0.8%
Esperion Therapeutics, Inc. logo

ESPR - Manufacturing

Esperion Therapeutics, Inc.

P/E-Ratio
-1.9
Total Investment
$62.3 Thousand
Weight
0.8%
IGM Biosciences, Inc. logo

IGMS - Manufacturing

IGM Biosciences, Inc.

P/E-Ratio
-1.3
Total Investment
$62.1 Thousand
Weight
0.8%
Inovio Pharmaceuticals, Inc. logo

INO - Manufacturing

Inovio Pharmaceuticals, Inc.

P/E-Ratio
-2.1
Total Investment
$62 Thousand
Weight
0.8%
Bandwidth Inc. logo

BAND - Information

Bandwidth Inc.

P/E-Ratio
-30.1
Total Investment
$62 Thousand
Weight
0.8%
Sutro Biopharma, Inc. logo

STRO - Professional, Scientific, and Technical Services

Sutro Biopharma, Inc.

P/E-Ratio
-3.0
Total Investment
$61.9 Thousand
Weight
0.7%